Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A Total Liabilities

As of the most recent data (March 2026), FBIOP shows a total liabilities of $150M. That compares with $150M in the prior-year period — up 6.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FBIOP's total liabilities is now $150M (was $150M) — a 6.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A is outperforming or lagging.

Tracking FBIOP's total liabilities over time shows whether Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A is scaling, shrinking, or reshaping that part of the business. The current reading is $150M That compares with $150M in the prior-year period — up 6.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $150M) with ownership activity and broader fundamentals.

Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A's total liabilities is $150M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.